10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(MARK ONE)

ýQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2018

OR

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-38334

IMMERSION CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	94-3180138
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

50 Rio Robles, San Jose, California 95134

(Address of principal executive offices)(Zip Code)

(408) 467-1900

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý     No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	ý
Non-accelerated filer	¨(Do not check if a smaller reporting company)	Smaller Reporting Company	¨
		Emerging Growth Company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨    No  ý

Number of shares of common stock outstanding at May 4, 2018: 30,367,214.

EXPLANATORY NOTE

On May 11, 2018, Immersion Corporation (the “Company”) filed the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2018 (the “Form 10-Q”). The Company is filing this Amendment No. 1 to Form 10-Q (“Amendment No. 1”) to file an amended Exhibit 10.2 (Settlement and License Agreement, between Immersion and Apple Inc., dated as of January 26, 2018). Certain portions of the information omitted from the Exhibit 10.2 filed with the Form 10-Q pursuant to a confidential treatment request have now been included in the Exhibit 10.2 filed with this Amendment No. 1.

As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company has set forth the complete text of Item 6, as amended. This Amendment No. 1 speaks as of the filing date of the Form 10-Q, does not update information in the Form 10-Q to reflect events that have occurred subsequent to the filing date of the Form 10-Q, and does not modify or update in any way disclosures made in the Form 10-Q. Except as described above, no other amendments are being made to the Form 10-Q. Accordingly, this Amendment No. 1 should be read in conjunction with the Form 10-Q and the Company’s subsequent filings made with the Securities and Exchange Commission since May 11, 2018. The filing of this Amendment No. 1 shall not be deemed an admission that the Form 10-Q, when made, included any untrue statement of a material fact or omitted to state a material fact necessary to make a statement not misleading.

PART II

OTHER INFORMATION

ITEM 6. EXHIBITS

The exhibits listed in the accompanying “Exhibit Index” are filed or incorporated by reference as part of this Form 10-Q.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: July 30, 2018

IMMERSION CORPORATION
By	/s/ Nancy Erba
	Nancy Erba
	Chief Financial Officer and Principal Accounting Officer

4

EXHIBIT INDEX

Exhibit Number	Exhibit Description	Incorporated by Reference				Filed Herewith
		Form	File No.	Exhibit	Filing Date
10.1	Separation Agreement dated January 2, 2018 between Immersion and Victor Viegas	8-K/A	001-38334	10.2	January 3, 2018
10.2 #	Settlement and License Agreement, between Immersion and Apple Inc., dated as of January 26, 2018		001-38334			X
10.4 **	Amended and Restated Retention and Ownership Change Agreement dated February 26, 2018 by and between Immersion and Nancy Erba	10-Q	001-38334	10.4	May 11, 2018
10.6 **	Amended and Restated Retention and Ownership Change Agreement dated February 26, 2018 by and between Immersion and Anne Marie Peters	10-Q	001-38334	10.6	May 11, 2018
31.1	Certification of Carl Schlachte, Interim Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					X
31.2	Certification of Nancy Erba, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					X
32.1*	Certification of Carl Schlachte, Interim Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					X
32.2*	Certification of Nancy Erba, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					X
101.INS	XBRL Report Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Presentation Linkbase Document

#	Certain portions of this exhibit have been omitted and filed separately with the SEC pursuant to a request for confidential treatment under Rule 24b-2 as promulgated under the Exchange Act.
*	This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
**	Constitutes a management contract or compensatory plan.

5

EX-10.2

NOTE: THIS DOCUMENT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. PORTIONS OF THIS DOCUMENT FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED HAVE BEEN REDACTED AND ARE MARKED HEREIN BY “[***]”. SUCH REDACTED INFORMATION HAS BEEN FILED SEPARATELY WITH THE COMMISSION PURSUANT TO THE CONFIDENTIAL TREATMENT REQUEST.

SETTLEMENT AND LICENSE AGREEMENT

This Settlement and License Agreement (“Agreement”) is made as of January 26, 2018 (“Effective Date”) between Apple Inc., a California corporation (“Apple”) and Immersion Corporation, a Delaware corporation (“Immersion”). As used herein, “Party” refers to either Immersion or Apple, and “Parties” refers to Immersion and Apple collectively.

WHEREAS, Apple desires to acquire a non-exclusive license under [***] patents [***], and to resolve any disputes related thereto.

WHEREAS Immersion brought suit against Apple in United States International Trade Commission Inv. Nos. 337-TA-1004/990 (consolidated); Immersion Corp. v. Apple Inc., et al., Civil Action Nos. 1:16-cv- 00077 and 1:16-cv- 00325 (D. Delaware); and an action in the Beijing High People’s Court against Apple Computer Trading (Shanghai) Co., Ltd., Apple Electronic Product Commerce (Beijing) Co., Ltd., and Apple Trading (Shanghai) Co., Ltd. (collectively, the “Lawsuit”); and

WHEREAS the Parties now desire to settle the Lawsuit and enter into this agreement providing for a [***] settlement of the subject matter of the Lawsuit and for certain [***], all on the terms and conditions set forth herein.

NOW, THEREFORE, in consideration of the above premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows:

1.0     DEFINITIONS.

1.1    “Licensed Product” means [***] product, product line, service, device, system, component, hardware, software, any combination of the foregoing, or other offering that is designed, branded, made, used, sold, offered for sale, leased, purchased, licensed, imported, exported, supplied or otherwise provided [***].  For the avoidance of doubt, any of the above enumerated items that is not designed, branded, made, used, sold, offered for sale, leased, purchased, licensed, imported, exported, supplied or [***] shall not

Page 1CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

qualify as a Licensed Product even if such item is identical or similar to an item that is supplied or [***]. Notwithstanding the above, no right to become a foundry to third parties other than [***] is granted under this Agreement.

1.2    “Immersion Patents” means (i) [***] patents and patent applications (along with patents issuing thereon) [***] that are, as of the Effective Date, [***], including without limitation U.S. Patent Numbers 8,772,356, 8,619,051, 8,659,571, 7,336,260, 7,808,488, 8,749,507, 8,581,710, and (ii) any divisional, continuation, continuation-in-part, reissue, reexamination, utility model, foreign counterpart, parent or extension of any patent or application included in Section 1.2(i) or (ii), and any patent or patent application whose [***]. Notwithstanding anything to the contrary, the term “Immersion Patents” do not include: (a) patents and patent applications owned or controlled by a third party that acquires Immersion or any of its Affiliates after the Effective Date, whether by merger, acquisition, or purchase of all or substantially all of the assets of Immersion or its Affiliates; (b) patents and patent applications owned or controlled by a third party that is acquired by Immersion or any of its Affiliates after the Effective Date, whether by merger, acquisition, or purchase of all or substantially all of the assets of such third party; or (c) Conditional Patents.

1.3    “Conditional Patents” shall mean a patent or patent application for which the grant of licenses, releases, or freedom from suit to a third party results in an obligation to pay, or the payment of, additional royalties by Immersion or any of its Affiliates to a third party owner or a third party licensor of the patent or patent application. Immersion represents and warrants that, as of the Effective Date, [***].

1.4    “Affiliate” means, with respect to a person, corporation or other entity, any other person, corporation or entity that directly or indirectly controls, is controlled by, or is under common control with such corporation or entity. For purposes of this definition, “control” means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a person, corporation or other entity whether through the ownership of voting securities, by contract or otherwise. Notwithstanding the above, Affiliates shall not include any Excluded Apple Assignees.

1.5    “Covered Apple Parties” means Apple, [***], in each case, solely to exercise the rights set forth in Section 2 with respect to Licensed Products.

1.6    “Excluded Apple Assignee” shall mean, [***].

1.7    “Pending Inter Partes Reviews” shall mean: (a) the proceedings pending in the United States Patent and Trademark Office to conduct an inter partes review of Immersion patents based on petitions Apple filed with the Patent Trial and Appeal Board (“PTAB” or “Board”), including the following IPRs: IPR2016-1372 (’571 patent), IPR2016-1381 (’356 patent), IPR2016-1603 (’710 patent), IPR2016-1884 (’260 patent), and IPR2016-1907 (’488 patent), (b) the Requests for Reexaminations and Invalidation at the State Intellectual Property Office of the People’s Republic of China of Chinese Patent No. ZL02821854.X and Chinese Patent No. ZL200810008845.X, and (c) any other pending

Page 2CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

proceedings by Apple or its Affiliates challenging or contesting the validity or enforceability of the Immersion Patents.

2.0 LICENSE AND RELEASE.

2.1    License. Subject to the terms and conditions of this Agreement [***] and solely during the Term, Immersion, on behalf of itself, its Affiliates, and their successors and assigns, grants to the Covered Apple Parties a [***] license under the Immersion Patents to make, have made, use, purchase, sell, offer for sale, license, lease, import, export, or otherwise dispose of [***].

2.2    Covenant. In addition to Sections 2.1

2.2.1 By Immersion. In addition to [***], and effective and conditioned upon [***], Immersion, on behalf of itself, its Affiliates, and their successors and assigns, hereby covenants not to sue the Covered Apple Parties for infringement of the Immersion Patents with respect to Licensed Products licensed above in Section 2.1. No Licensed Product shall be used to satisfy any claim or claim element asserted by Immersion or its Affiliates, and their successors and assigns, against Apple, its Affiliates, their successors and assigns, customers, users, licensees, service providers, distributors, retailers, or direct and indirect suppliers. Notwithstanding anything to the contrary in this Agreement, the covenant not to sue in this Section 2.2.1 shall not: (a) preclude Immersion or any of its Affiliates from bringing a claim for a breach of this Agreement; or (b) prevent Immersion from bringing an infringement suit against a Covered Apple Party or its Affiliates after the termination or expiration of this Agreement for actions that occur after termination or expiration of this Agreement, or with respect to patents that are not Immersion Patents.

2.2.2 By Apple. Apple, on behalf of itself, its Affiliates, and their successors and assigns, hereby covenants not to sue Immersion, its Affiliates, their successors and assigns, direct or indirect customers, users, licensees, service providers, distributors, retailers, or direct and indirect suppliers for any claims related to the Immersion Patents, and covenants not to contest or assist in the contest in any forum, including federal courts, whether under 28 U.S.C. §§ 2201-2202 or not, United States Patent and Trademark Office, and/or the International Trade Commission, that the Immersion Patents are valid and enforceable. This section shall not apply, however, if Immersion, or its Affiliates, successors, directors, employees, or agents (a) breaches the covenant not to sue of Section 2.2.1 in any regard; (b) acts in a manner inconsistent with the licenses and releases of Sections 2.1 and 2.3 in any regard; or (c) alleges or claims that any Covered Apple Party infringes or will infringe the Immersion Patents based on Licensed Products.  This section shall not preclude Apple, or any Apple Affiliate, successor, assign, predecessor, customer, or supplier, who receives a lawful subpoena, discovery request, Court or administrative order, or any other form of legal process or government directive, from responding to such a request, order, or directive by producing or providing documents, testimony, or other information.

2.3 Release.

Page 3CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

2.3.1 By Immersion. [***],Immersion, on behalf of itself, its Affiliates, and their successors and assigns hereby releases, acquits and forever discharges the Covered Apple Parties from any and all actions, causes of action, claims or demands, liabilities, losses, damages, attorney fees, court costs, or any other form of claim or compensation, whether known or unknown as of the Effective Date, arising out of the facts, events or occurrences underlying or giving rise to or otherwise related to, [***] any released party on account of any such claim. For the avoidance of doubt, the release set forth in this Section 2.3.1 shall not prevent Immersion from bringing an infringement suit against a Covered Apple Party or its Affiliates after the termination or expiration of this Agreement for actions that occur after termination or expiration of this Agreement, or with respect to patents that are not Immersion Patents.

2.3.2 By Apple. In addition to Section 2.2, Apple, on behalf of itself, its Affiliates, and their successors and assigns hereby releases, acquits and forever discharges Immersion (together with its Affiliates, predecessors, successors, agents, attorneys, insurers, servants, distributors, licensees, service providers, retailers, suppliers, employees, officers, directors, users and customers) from any and all actions, causes of action, claims or demands, liabilities, losses, damages, attorney fees, court costs, or any other form of claim or compensation, whether known or unknown as of the Effective Date, [***]. This section shall not apply, however, if Immersion, or its Affiliates, successors, directors, employees, or agents (a) breaches the covenant not to sue of Section 2.2 in any regard; (b) acts in a manner inconsistent with the licenses and releases of Sections 2.1 and 2.3.1 in any regard; or (c) alleges or claims that Apple, any Apple Affiliate, or any Apple successor, assign, predecessor, customer, or supplier infringes or will infringe the Immersion Patents based on Licensed Products.

2.4    Each Party, having specific intent to release all potential claims described in the foregoing Sections 2.1, 2.2, and 2.3, whether known or unknown, does hereby acknowledge and expressly waive the provisions of Section 1542 of the California Civil Code (and similar provisions in other jurisdictions, whether by statute or common law), which provides:

“A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her, must have materially affected his settlement with debtor.”

2.5    Dismissal. [***],Immersion shall submit on behalf of the parties (i) in the ITC, a motion to terminate the ITC Investigation in substantially the form attached hereto as Exhibit A-1; (ii) in the District Court for the United States District of Delaware, a joint stipulation of dismissal of all claims with prejudice and counterclaims without prejudice, in substantially the form attached hereto as Exhibit A-2; (iii) documents requesting the termination and dismissal of all pending IPRs in substantially the form attached hereto as Exhibit A-3 or otherwise mutually agreed upon by the parties; and (iv) a request that the

Page 4CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

action before the Beijing High People’s Court be dismissed with prejudice in a form satisfactory to Immersion’s counsel in the Chinese action. In the event that papers other than those attached hereto as exhibits are required to effectuate the dismissal, the parties will cooperate in order to prepare such papers and effectuate the dismissal of the Lawsuit. Immersion and Apple, on behalf of themselves and their Affiliates, further agree to take no additional action to prosecute the Lawsuit against the other party (except that Immersion may appeal the ‘571 patent IPR and the ‘356 patent IPR if those proceedings are not terminated pursuant to the motion of the parties), including seeking any discovery or other relief, after such request for dismissal is made. Apple makes no admission of infringement or liability by the negotiation, execution, or performance of this Agreement.

2.6    To the extent that Immersion does not have the right to grant fully the releases, licenses, covenants and other rights set out in this Agreement, it grants the broadest such rights that it is entitled to grant consistent with the terms set out herein.

3.0    CONSIDERATION.

3.1    [***], Apple will pay to Immersion [***] which is non-refundable and non-creditable. [***]

3.2    Option. Subject to the terms and conditions of this Section 3.2, if Apple provides written notice of its intent to exercise the option described in this Section 3.2 (the “Option”) and agrees to pay Immersion [***] (the “Option Fee”), then the Term shall be automatically extended until the expiration of the last Immersion Patent. The Option Fee shall be non-refundable and non-creditable if paid. The payments described in [***] shall be the [***] compensation paid to Immersion for the rights granted in this Agreement, and [***]. Payment of the Option Fee shall be made by electronic transfer of funds to Immersion’s bank account set forth in Section 3.1 (or such other Immersion bank account as Immersion provides to Apple). Immersion shall provide notice to Apple [***] informing Apple of the its right to exercise the Option. Such notice shall include the deadline by which Apple is required to accept the Option, which deadline shall be no earlier than [***] and shall attach an updated wire instructions and Form W-9 (or equivalent). Notwithstanding the foregoing, the Option shall remain available to Apple until [***] pursuant to the Agreement. If Apple exercises the Option, then the Option Fee shall be due within [***] of the date that Apple exercises the Option.

3.3    Attached as Exhibit C to this Agreement is Immersion’s IRS Form W-9.   Immersion will be responsible for any duties, taxes, and levies resulting from any payment hereunder.

4.0    WARRANTIES.

4.1    Apple warrants and represents that it is a validly existing business and in good standing under the laws of the respective jurisdictions in which it has activities, and

Page 5CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

has the full power and authority to enter into this Agreement and to perform its obligations hereunder and consummate the transactions contemplated herein.

4.2    Immersion represents and warrants to Apple that: (a) it has all requisite legal right, power and authority to execute, deliver and perform this Agreement; (b) as of the Effective Date, it owns or otherwise has the right to license the Immersion Patents, and that no other third party owns any right to enforce or recover for infringement of the Immersion Patents by Apple or its Affiliates; (c) it has not granted and will not grant any licenses or other rights, under the Immersion Patents or otherwise, that would conflict with or prevent the licenses, covenants, releases and rights granted to Apple and its Affiliates hereunder; and (d) it has not sold or assigned patents or patent applications since the filing of the Lawsuit. Immersion represents and warrants that there are no liens, conveyances, mortgages, assignments, encumbrances, or other agreements that would prevent or impair the full and complete exercise of the terms of this Agreement. Immersion agrees to indemnify and hold Apple and its Affiliates harmless from any claim brought by a third party who claims any interest in, or any right to recover under any Immersion Patent. Immersion shall not grant or assign any rights under the Immersion Patents, unless such grants or assignments are made subject to the rights granted in this Agreement.

4.3    As of the Effective Date, Immersion represents and warrants that it does not directly or indirectly own or control, nor is it owned or controlled by or in common with, any other company or other entity that owns any patents or patent applications other than the Immersion Patents. The express purpose of this clause is to permit Apple to understand all patent rights that could be asserted against it by anyone having an interest in the Immersion Patents; as such, any omission is deemed material to this entire Agreement. In the event that, and notwithstanding this representation and warranty of Section 4.3, there are other patents that are directly or indirectly owned or controlled by Immersion or another entity that is owned or controlled by or in common with Immersion, then such other patents shall be treated as if they were Immersion Patents for the purposes of all licenses, covenants, releases and other rights granted in this Agreement.

5.0    TERM AND TERMINATION.

5.1    This Agreement shall commence as of the Effective Date and continue until January 26, 2028 (the “Term”); provided that if Apple exercises the Option and pays the Option Fee to Immersion in accordance with Section 3.2, then this Agreement shall continue until the expiration of the last Immersion Patent. Upon expiration or termination of the Term, the licenses and covenants not to sue set forth in this Agreement shall cease.

5.2    Other than as set forth in Section 5.1, this Agreement may only be terminated by mutual written agreement of the Parties.

Page 6CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

6.0 ASSIGNABILITY.

6.1    Neither party may grant or assign any rights or delegate any duties under this Agreement to any third party without the prior written consent of the other, and any attempted assignment without such consent shall be null and void. Notwithstanding the foregoing, Apple may (i) assign rights under this Agreement to any of its Affiliates, except any Excluded Apple Assignee and (ii) assign rights under this Agreement to (a) an acquirer of all or substantially all of the equity or assets of its business to which this Agreement relates or (b) the surviving entity in any merger, consolidation, equity exchange, or reorganization of its business to which this Agreement relates, provided however that the licenses and/or covenants not to sue as applied to such acquirer or surviving entity is limited to products and services that qualify as Licensed Products and equivalent generations thereof as of the effective date of the applicable transaction in (ii); and (2) Immersion may (i) assign rights under this Agreement to any of its Affiliates, (ii) assign this Agreement to an acquirer of all or substantially all of the equity or assets of its business to which this Agreement relates, or (iii) the surviving entity in any merger, consolidation, equity exchange, or reorganization of its business to which this Agreement relates. All license rights and covenants contained herein shall run with the Immersion Patents and shall be binding on any successors-in-interest or assigns thereof. Immersion and its Affiliates shall not assign any Immersion Patent to any other party unless such assignment or grant is subject to all of the terms and conditions of this Agreement. Any attempted assignment or grant in contravention of this Section 6.1 shall be null and void. This Agreement shall be binding upon, inure to the benefit of and be enforceable by the Parties and their permitted successors and assigns.

7.0 CONFIDENTIALITY.

7.1    The terms of this Agreement and all correspondence relating to this Agreement are confidential. The Parties shall keep terms and particulars of this Agreement strictly confidential and no Party shall now or hereafter disclose such terms and particulars to any third party except: (i) with the prior written consent of the other Party, (ii) as may be required by applicable law, regulation or order of a governmental authority of competent jurisdiction, (iii) during the course of litigation so long as the disclosure of such terms and conditions is subject to the same restrictions as is the confidential information of the other litigating parties, such restrictions are embodied in a court-entered protective order limiting disclosure to outside counsel and such disclosing Party provides the other Party written notice at least ten (10) business days prior to such disclosure, (iv) in confidence to the professional legal and financial counsel representing such Party, or (v) in confidence to any party covered by the releases, licenses or covenants granted herein. With respect to the foregoing (ii), such disclosing Party shall, to the extent legally permissible, provide the other Party with prior written notice of such applicable law, regulation or order and, at the request of the other Party, use reasonable efforts to limit the disclosure of the terms and conditions of this Agreement, and to obtain a protective order or other confidential treatment.

Page 7CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

7.2    Immersion may issue a press release as set forth in Exhibit D. Except with respect to such press release, neither Party shall issue a press release or make any other public statement regarding this Agreement or the settlement of the Lawsuit, except that Apple and Immersion may make any statement it deems appropriate to satisfy its various public reporting obligations. Immersion, and its representatives and counsel, shall not directly or indirectly seek any publicity regarding this Agreement, the settlement, or any litigation with Apple by any means, including but not limited to, initiating or responding to any inquiry by the press concerning Apple, the Agreement, the settlement, or the Lawsuit. If a third party expressly inquires about the Lawsuit or the Agreement, the only statements that a Party may provide in response, without breach of the provisions herein, are (i) that [***]; and (ii) to direct the third party [***].

7.3    The confidentiality provisions of this Agreement are material terms of this Agreement, and any breach of these provisions will constitute a material breach of this Agreement. The failure of any Party to enforce at any time any of the provisions governing the confidentiality of the terms of this Agreement or to require at any time performance by any of the Parties of any such provisions shall in no way be construed as a waiver of such provision or relinquishment of the right thereafter to enforce such provision.

8.0 NOTICES.

8.1    All notices required or permitted to be given hereunder shall be in writing and shall be deemed delivered (i) upon receipt if delivered by hand, (ii) the next business day after being sent by prepaid, nationally-recognized, overnight air courier, (iii) five (5) business days after being sent by registered or certified airmail, return receipt required, postage prepaid, or (iv) upon transmittal when transmitted by confirmed telecopy (provided that such notice is followed notice pursuant to any of (i) – (iii) above).

8.2    All notices shall be addressed as follows:

Page 8CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

For Apple:	And with a copy to:
General Counsel Apple Inc. One Apple Park, 301-4GC Cupertino, CA 95014 Fax: (408) 974-8530	Chief IP Counsel Apple Inc. One Apple Park, 169-3IPL Cupertino, CA 95014 Fax: (408) 974-4992
	And (for Section 7 notices only) with a copy to: prod_requests@apple.com
For Immersion:
General Counsel Immersion Corporation 50 Rio Robles San Jose, California 95134

9.0 MISCELLANEOUS.

9.1    Immersion has no obligation hereunder to institute any action or suit against any third party for infringement of any of the Immersion Patents, or to defend against any action challenging the validity of the Immersion Patents. Apple has no right to institute any action against any third party for infringement of any Immersion Patent.

9.2    Immersion agrees on behalf of itself, its Affiliates, and their successors and assigns not to claim that the rights conveyed to Apple in this Agreement or Apple’s alleged practice of any Immersion Patent are evidence of a domestic industry pursuant to Section 337(a) of the Tariff Act of 1930 or any similar foreign or domestic statute, and hereby irrevocably waives any such argument.

9.3    Nothing in this Agreement is intended or shall be deemed to constitute a partnership, agency, employer-employee, or joint venture relationship between the Parties. Neither Party shall incur any debts or make any commitments for the other. There is no fiduciary duty or special relationship of any kind between the Parties to this Agreement. Each Party expressly disclaims any reliance on any act, word, or deed of the other Party in entering into this Agreement.

9.4    Nothing contained in this Agreement shall be construed as conferring any right to a license or to otherwise use any patent, patent application, trademark, service name, service mark, trade dress, trade secret or other intellectual property belonging to Apple.

9.5    If any portion of this Agreement is found to be invalid, illegal, or unenforceable for any reason, the remainder of the Agreement shall continue in force and,

Page 9CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

if needed, the Parties or a court of competent jurisdiction shall substitute suitable provisions having like economic effect and intent.

9.6    This Agreement cannot be modified, terminated or amended in any respect orally or by conduct of the Parties. Any termination, modification, or amendment may be made only by a writing signed by all Parties. No waiver of any provision shall be binding in any event unless executed in writing by the Party making the waiver.

9.7    This Agreement may be executed in several counterparts (including via PDF, facsimile, or electronic signature), each of which is deemed to be an original but all of which constitute one and the same instrument.

9.8    Each Party and counsel have reviewed and approved this Agreement, and accordingly any presumption or rule of construction permitting ambiguities to be resolved against the drafting party shall not be employed in the interpretation or application of this Agreement.

9.9    The headings inserted in this Agreement are for reference only and are not intended to form any part of the operative portion of this Agreement, and they shall not be employed in the interpretation or application of this Agreement.

9.10    This Agreement shall be construed, and the relationship between the Parties determined, in accordance with the laws of Delaware, notwithstanding any choice-of-law principle that might dictate a different governing law. Each Party irrevocably agrees, consents and submits to jurisdiction and venue in the federal and state courts located within Santa Clara County, California, with respect to any dispute arising out of or relating in any way to this Agreement. The Parties acknowledge that Apple is headquartered in Santa Clara County and that Immersion conducts business in Santa Clara County, and the Parties hereby waive all defenses based upon forum non conveniens, improper venue,or personal jurisdiction.

9.11    This Agreement sets forth the entire understanding of the Parties with respect to the Immersion Patents, and replaces any prior oral or written communications, discussions or agreements between them.

9.12    The remedy for breach of this Agreement shall be limited to damages and/or injunctive relief, as appropriate, for breach of contract and shall not include remedies for patent infringement. The immediately preceding sentence shall not apply with respect to any breach of this Agreement [***].

9.13    EXCEPT WITH RESPECT TO A CLAIM OF INFRINGEMENT OF ONE PARTY’S INTELLECTUAL PROPERTY RIGHTS AGAINST THE OTHER PARTY TO THIS AGREEMENT AND EXCEPT AS OTHERWISE PROVIDED EXPLICITLY HEREIN, IN NO EVENT SHALL ANY PARTY BE LIABLE TO ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY (UNDER CONTRACT, STRICT LIABILITY,

Page 10CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

NEGLIGENCE, OR OTHER THEORY) FOR SPECIAL, INDIRECT, EXEMPLARY, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, INCLUDING LOST PROFITS, OPPORTUNITIES OR SAVINGS, ARISING OUT OF OR RELATED TO THE SUBJECT MATTER OF THIS AGREEMENT. IN NO EVENT WILL IMMERSION’S AGGREGATE LIABILITY UNDER ALL CLAIMS UNDER OR IN CONNECTION WITH THIS AGREEMENT, WHETHER SUCH CLAIMS ARE IN CONTRACT, TORT, OR ANY OTHER THEORY OF LIABILITY, [***]. The parties acknowledge that the limitations of liability in this Section 9.13 and in the other provisions of this Agreement and the allocation of risk herein are an essential element of the bargain between the parties, without which Immersion would not have entered into this Agreement.

9.14    The Parties acknowledge and agree that the Immersion Patents are “intellectual property” as defined in Section 101(35A) of the United States Bankruptcy Code (the “Code”), as the same may be amended from time to time, that have been licensed hereunder in a contemporaneous exchange for value. Immersion acknowledges that if Immersion, as a debtor in possession or a trustee in bankruptcy in a case under the Code, rejects this Agreement, Apple may elect to retain its rights under this Agreement as provided in Section 365(n) of the Code. Upon written request from Apple to Immersion or the bankruptcy trustee of Immersion’s election to proceed under Section 365(n), Immersion or the bankruptcy trustee shall comply in all respects with Section 365(n), including, without limitation, by not interfering with the rights of Apple as provided by this Agreement.

[SIGNATURE PAGE FOLLOWS]

Page 11CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

IN WITNESS WHEREOF, this Agreement has been duly executed by the Parties to be effective as of the Effective Date.

APPLE INC.	IMMERSION CORP.
By: /s/ Noreen Krall	By: /s/ Carl Schlachte
Name: Noreen Krall Its: Vice President, Chief Litigation Counsel	Name: Carl Schlachte Its: Interim Chief Executive Officer
Dated: January 26, 2018	Dated: January 26, 2018

Page 12CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EXHIBIT A-1

[MOTION TO TERMINATE ITC INVESTIGATION ATTACHED]

Page 13CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

UNITED STATES INTERNATIONAL TRADE COMMISSION

Washington, D.C.

Before the Honorable Charles E. Bullock

Chief Administrative Law Judge

In the Matter of:
CERTAIN MOBILE ELECTRONIC DEVICES
INCORPORATING HAPTICS (INCLUDING	Inv. No. 337-TA-1004
SMARTPHONES AND SMARTWATCHES)	Inv. No. 337-TA-990
AND COMPONENTS THEREOF	(Consolidated)
CERTAIN MOBILE AND PORTABLE
ELECTRONIC DEVICES INCORPORATING
HAPTICS (INCLUDING SMARTPHONES
AND LAPTOPS) AND COMPONENTS
THEREOF

JOINT MOTION TO TERMINATE THE INVESTIGATION

ON THE BASIS OF A SETTLEMENT AGREEMENT

Complainant Immersion Corporation (“Immersion”) and Respondents Apple Inc. (“Apple”) and AT&T Mobility LLC (“AT&T”) hereby jointly move to terminate the above captioned consolidated Investigation pursuant to 19 C.F.R. § 210.21(b) based on an agreement to settle the dispute underlying the Investigation. This motion is based on the following settlement agreement submitted herewith:

• Exhibit __ [Confidential Agreement]

• Exhibit __ [Public Version]

Other than the attached settlement agreement and the stipulations filed in this Investigation, there are no other agreements written or oral, express or implied, between Immersion and Respondents concerning the subject matter of this Investigation.

Page 14CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

The Settlement Agreement between Immersion and Respondents contains Confidential Business Information (“CBI”) within the meaning of 19 C.F.R. § 201.6. Immersion and Respondents therefore request that the Settlement Agreement attached hereto as Exhibit ___ be treated as CBI under the Protective Order (Order No. 1) in this Investigation. A public version of this agreement with the CBI redacted is attached hereto as Exhibit ___.

Ground Rule 3.2 Certification

Pursuant to Ground Rule 3.2, Immersion certifies that reasonable, good-faith efforts to resolve these matters with Respondents and Staff were made at least two business days prior to filing this motion. Respondents have joined the motion and are submitting this motion jointly with Complainant. Staff ______.

Dated: January __, 2018Respectfully submitted,

/s/	/s/
Morgan Chu	Mark D. Fowler
Richard Birnholz	Christine Corbett
Lisa Glasser	Robert Buergi
Rebecca Carson	DLA PIPER LLP (US)
Babak Redjaian	2000 University Avenue
Maclain Wells	East Palo Alto, CA 94303-2215
Tony Rowles	Telephone: (650) 833-2000
Stephen Payne	Facsimile: (650) 833-2001
Irell & Manella LLP
1800 Avenue of the Stars, Suite 900	Sean C. Cunningham
Los Angeles, CA 90067	Erin P. Gibson
Telephone: (310) 277-1010	Robert Williams
Facsimile: (310) 203-7199	DLA PIPER LLP (US)
	401 B Street, Suite 2000
Barbara A. Murphy	San Diego, CA 92101-4240
David F. Nickel	Telephone: (619) 699-2700
Kandis C. Gibson	Facsimile: (619) 699-2701
Foster, Murphy, Altman & Nickel, PC
1899 L Street NW #1150	Brian Erickson
Washington, DC 20036	DLA PIPER LLP (US)

Page 15CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Telephone: (202) 822-4100	401 Congress Avenue, Suite 2500
Facsimile: (202) 822-4199	Austin, Texas 78701-3799
	Telephone: (512) 457-7000
Counsel for Complainant Immersion	Facsimile: (512) 457-7001
Corporation
	Counsel for Respondents Apple Inc. and
	AT&T Mobility LLC
	/s/
	Josh Krevitt
	Benjamin Hershkowitz
	George Stamatopoulos
	GIBSON, DUNN & CRUTCHER LLP
	200 Park Ave
	New York, NY 10166-0193
	Mark Reiter
	GIBSON, DUNN & CRUTCHER LLP
	2100 McKinney Ave Ste 1100
	Dallas, TX 75201-6912
	Telephone: (214) 698-3100
	Eric T. Syu
	GIBSON, DUNN & CRUTCHER LLP
	3161 Michelson Dr.
	Irvine, CA 92612-4412
	Telephone: (949) 451-3800
	Jill M. McCormack
	GIBSON, DUNN & CRUTCHER LLP
	1050 Connecticut Ave NW
	Washington, DC 20036-5306
	Telephone: (202) 955-8500
	Counsel for Respondent AT&T Mobility,
	LLC

Page 16CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

UNITED STATES INTERNATIONAL TRADE COMMISSION

Washington, D.C.

Before the Honorable Charles E. Bullock

Chief Administrative Law Judge

In the Matter of:
CERTAIN MOBILE ELECTRONIC DEVICES
INCORPORATING HAPTICS (INCLUDING	Inv. No. 337-TA-1004
SMARTPHONES AND SMARTWATCHES)	Inv. No. 337-TA-990
AND COMPONENTS THEREOF	(Consolidated)
CERTAIN MOBILE AND PORTABLE
ELECTRONIC DEVICES INCORPORATING
HAPTICS (INCLUDING SMARTPHONES
AND LAPTOPS) AND COMPONENTS
THEREOF

MEMORANDUM IN SUPPORT OF JOINT MOTION TO TERMINATE THE INVESTIGATION ON THE BASIS OF A SETTLEMENT AGREEMENT

Complainant Immersion Corporation (“Immersion”) and Respondents Apple Inc. (“Apple”) and AT&T Mobility LLC (“AT&T”) jointly move to terminate the above captioned Investigation pursuant to 19 C.F.R. § 210.21(b) based on the attached Settlement Agreement between Immersion and Respondents. See Confidential Exhibit __. The Settlement Agreement has been executed by Immersion and Respondents and completely resolves the dispute in this Investigation. Other than the attached settlement agreement and the stipulations filed in this Investigation, ¹ there are no other agreements written or oral, express or implied, between Immersion and Respondents concerning the subject matter of this Investigation.

Page 17CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Commission Rule 210.21(b) provides that “[a]n investigation before the Commission may be terminated as to one or more respondents pursuant to section 337(c) of the Tariff Act of 1930 on the basis of a licensing or other settlement agreement.” In determining whether to terminate an Investigation pursuant to a settlement, “the administrative law judge is directed to consider and make appropriate findings regarding the effect of the proposed settlement on the public health and welfare, competitive conditions in the United States economy, production of like or directly competitive articles in the United States, and United States consumers.” Certain Antivenom Compositions and Products Containing Same, Inv. No. 337-TA-903, Order No. 62, 2014 WL 6480574, at *1 (Nov. 13, 2014).

Immersion and Respondents submit that termination of this Investigation is in the public interest and will not have any adverse effect on the public health or welfare, competitive conditions in the United States, production of like or directly competitive articles in the United States, or United States consumers. Commission policy and the public interest generally favors settlements, which preserve Commission and party resources. See, e.g., Certain Wireless Consumer Electronic Devices and Components Thereof, Inv. No. 337-TA-853, Comm’n Op., 2013 WL 12313471 (Sep. 20, 2013) (“[T]he public interest favors settlement to avoid needless litigation and to conserve public and private resources.”); Certain Consumer Electronic Devices, Including Televisions, Gaming Phones, and Tablets, Inv. No. 337-TA-1060, Order No. 27, 2017 WL 6629314 (Dec. 20, 2017) (same). Further, termination pursuant to a settlement is routinely granted in Commission Investigations. See, e.g., Certain Footwear Products, Inv. No. 337-TA-936, Order No. 57, 2015 WL 1802273 (Feb. 23, 2015); Certain Hemostatic Products

Page 18CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

and Components Thereof, Inv. No. 337-TA-913, Order No. 51, 2015 WL 1802261 (Apr. 2, 2015).

In accordance with 19 C.F.R. § 210.21(b), Immersion and Respondents are providing both confidential and public versions of the Settlement Agreement with this motion. Confidential Exhibit __ is the complete and un-redacted Settlement Agreement, and Exhibit __ is the public version of the Agreement.

For the foregoing reasons, Immersion and Respondents respectfully request that the Commission terminate this Investigation, allow them to file the Settlement Agreement as CBI, and approve the proposed public versions of the Settlement Agreement.

¹ The Parties filed the following stipulations in this Investigation: (1) Joint Initial Discovery Stipulations (Apr. 11, 2016) (Doc. ID 578277); (2) Stipulation and Agreement to Terminate AT&T Inc. as a Proposed Respondent (May 9, 2016) (Doc. ID 580714); (3) Stipulation and Agreement Regarding AT&T Accused Products (Aug. 11, 2016) (Doc. ID 587832); (4) Joint Stipulation on Importation and Inventory (Dec. 14, 2016) (Doc. ID 598054); (5) Joint Stipulation on Importation and Inventory (Jan. 11, 2017) (Doc. ID 600692); (6) Stipulation and Agreement Regarding AT&T Accused Products (Mar. 30, 2017) (Doc. ID 607073); (7) Joint Stipulation Regarding Certain Fact Witnesses Not Testifying Live at the Hearing and Admission of Deposition Testimony (Apr. 14, 2017) (Doc. ID 608746); and (8) Joint Stipulation Regarding the Treatment of Source Code Exhibits at Trial (Apr. 28, 2017) (Doc. ID 610033).

Page 19CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Dated: January __, 2018Respectfully submitted,

/s/	/s/
Morgan Chu	Mark D. Fowler
Richard Birnholz	Christine Corbett
Lisa Glasser	Robert Buergi
Rebecca Carson	DLA PIPER LLP (US)
Babak Redjaian	2000 University Avenue
Maclain Wells	East Palo Alto, CA 94303-2215
Tony Rowles	Telephone: (650) 833-2000
Stephen Payne	Facsimile: (650) 833-2001
Irell & Manella LLP
1800 Avenue of the Stars, Suite 900	Sean C. Cunningham
Los Angeles, CA 90067	Erin P. Gibson
Telephone: (310) 277-1010	Robert Williams
Facsimile: (310) 203-7199	DLA PIPER LLP (US)
	401 B Street, Suite 2000
Barbara A. Murphy	San Diego, CA 92101-4240
David F. Nickel	Telephone: (619) 699-2700
Kandis C. Gibson	Facsimile: (619) 699-2701
Foster, Murphy, Altman & Nickel, PC
1899 L Street NW #1150	Brian Erickson
Washington, DC 20036	DLA PIPER LLP (US)
Telephone: (202) 822-4100	401 Congress Avenue, Suite 2500
Facsimile: (202) 822-4199	Austin, Texas 78701-3799
	Telephone: (512) 457-7000
Counsel for Complainant Immersion	Facsimile: (512) 457-7001
Corporation
	Counsel for Respondents Apple Inc. and
	AT&T Mobility LLC
	/s/
	Josh Krevitt
	Benjamin Hershkowitz
	George Stamatopoulos
	GIBSON, DUNN & CRUTCHER LLP
	200 Park Ave
	New York, NY 10166-0193
	Telephone: (212) 351-4000
	Mark Reiter
	GIBSON, DUNN & CRUTCHER LLP

Page 20CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

2100 McKinney Ave Ste 1100

Dallas, TX 75201-6912

Telephone: (214) 698-3100

2100 McKinney Ave Ste 1100

Dallas, TX 75201-6912

Telephone: (214) 698-3100

Eric T. Syu

GIBSON, DUNN & CRUTCHER LLP

3161 Michelson Dr.

Irvine, CA 92612-4412

Telephone: (949) 451-3800

Jill M. McCormack

GIBSON, DUNN & CRUTCHER LLP

1050 Connecticut Ave NW

Washington, DC 20036-5306

Telephone: (202) 955-8500

Counsel for Respondent AT&T Mobility,

LLC

Page 21CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

APPENDIX OF EXHIBITS IN SUPPORT OF JOINT MOTION TO TERMINATE THE INVESTIGATION ON THE BASIS OF A SETTLEMENT AGREEMENT

Ex. No. Description

Page 22CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EXHIBIT A-2

[JOINT STIPULATION (DE) ATTACHED]

Page 23CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF DELAWARE

IMMERSION CORPORATION, Plaintiff, vs. APPLE INC., AT&T INC., and AT&T MOBILITY LLC, Defendants. ) ) ) ) ) ) ) ) ) ) ) C.A. No. 16-077 (RGA)

JOINT STIPULATION TO DISMISS PURSUANT TO RULE 41

OF THE FEDERAL RULES OF CIVIL PROCEDURE

Pursuant to Rule 41(a)(1) of the Federal Rules of Civil Procedure and the agreements of the Parties, Plaintiff Immersion Corporation (“Immersion”) and Defendants Apple Inc. (“Apple”), AT&T Inc. (“AT&T”), and AT&T Mobility LLC (“AT&T Mobility”), (collectively the “Parties”), by and through counsel, hereby stipulate to the dismissal of this entire action as follows:

1.    All claims asserted by Immersion against Defendants in the Complaint filed in this action are dismissed with prejudice in their entirety.

2.    The Parties shall each bear their own costs and attorney’s fees incurred in connection with this action.

Page 24CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Dated: January __, 2018            Respectfully submitted,

FARNAN LLP	DLA PIPER LLP (US)
/s/	/s/
Brian E. Farnan (#4089)	Denise S. Kraft (#2778)
Michael J. Farnan (#5165)	Brian A. Biggs (#5591)
919 North Market Street, 12th Floor	1201 North Market Street, Suite 2100
Wilmington, DE 19801	Wilmington, DE 19801-1147
(302) 777-0300	(302) 468-5700
bfarnan@farnanlaw.com	denise.kraft@dlapiper.com
mfarnan@farnanlaw.com	brian.biggs@dlapiper.com
IRELL & MANELLA LLP	Attorneys for Defendant Apple Inc.
Morgan Chu (Cal. #70446)
Richard M. Birnholz (Cal. #151543)	MORRIS, NICHOLS, ARSHT & TUNNELL LLP
Lisa S. Glasser (Cal. #223406)
Babak Redjaian (Cal. #185506)	/s/
1800 Avenue of the Stars, Suite 900	Karen Jacobs (#2881)
Los Angeles, CA 90067	1201 North Market Street
Telephone: (310) 277-1010	P.O. Box 1347
Facsimile: (310) 203-7199	Wilmington, DE 19899-1347
	(302) 658-9200
Attorneys for Plaintiff Immersion	kjacobs@mnat.com
Corporation
	Attorneys for Defendants AT&T Inc. and
	AT&T Mobility LLC

SO ORDERED this ___ day of ____________, 2018

Hon. Richard G. Andrews

U.S. District Court Judge

Page 25CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF DELAWARE

IMMERSION CORPORATION, Plaintiff, vs. APPLE INC., AT&T INC., and AT&T MOBILITY LLC, Defendants. ) ) ) ) ) ) ) ) ) ) ) C.A. No. 16-00325 (RGA)

JOINT STIPULATION TO DISMISS PURSUANT TO RULE 41

OF THE FEDERAL RULES OF CIVIL PROCEDURE

Pursuant to Rule 41(a)(1) of the Federal Rules of Civil Procedure and the agreements of the Parties, Plaintiff Immersion Corporation (“Immersion”) and Defendants Apple Inc. (“Apple”), AT&T Inc. (“AT&T”), and AT&T Mobility LLC (“AT&T Mobility”), (collectively the “Parties”), by and through counsel, hereby stipulate to the dismissal of this entire action as follows:

1.    All claims asserted by Immersion against Defendants in the Complaint filed in this action are dismissed with prejudice in their entirety.

2.    The Parties shall each bear their own costs and attorney’s fees incurred in connection with this action.

Page 26CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Dated: January __, 2018            Respectfully submitted,

FARNAN LLP	DLA PIPER LLP (US)
/s/	/s/
Brian E. Farnan (#4089)	Denise S. Kraft (#2778)
Michael J. Farnan (#5165)	Brian A. Biggs (#5591)
919 North Market Street, 12th Floor	1201 North Market Street, Suite 2100
Wilmington, DE 19801	Wilmington, DE 19801-1147
(302) 777-0300	(302) 468-5700
bfarnan@farnanlaw.com	denise.kraft@dlapiper.com
mfarnan@farnanlaw.com	brian.biggs@dlapiper.com
IRELL & MANELLA LLP	Attorneys for Defendant Apple Inc.
Morgan Chu (Cal. #70446)
Richard M. Birnholz (Cal. #151543)	MORRIS, NICHOLS, ARSHT & TUNNELL LLP
Lisa S. Glasser (Cal. #223406)
Babak Redjaian (Cal. #185506)	/s/
1800 Avenue of the Stars, Suite 900	Karen Jacobs (#2881)
Los Angeles, CA 90067	1201 North Market Street
Telephone: (310) 277-1010	P.O. Box 1347
Facsimile: (310) 203-7199	Wilmington, DE 19899-1347
	(302) 658-9200
Attorneys for Plaintiff Immersion	kjacobs@mnat.com
Corporation
	Attorneys for Defendants AT&T Inc. and
	AT&T Mobility LLC

SO ORDERED this ___ day of ____________, 2018

Hon. Richard G. Andrews

U.S. District Court Judge

Page 27CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EXHIBIT A-3

[IPR DISMISSAL FORMS ATTACHED]

Page 28CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Email to Trials@ USPTO.gov

Dear Board:

The Parties have reached an agreement to resolve their disputes regarding the above­ referenced IPRs. Counsel for both parties request authorization to file a joint motion to terminate and dismiss in each of the following IPR proceedings under the Board’s authority under 37 C.F.R. §§ 42.72:

IPR2016-1372 ('57 l patent)

IPR20l6-l381 ('356 patent)

IPR2016-1603 ('7 l O paten t)

IPR2016-1884 ('260 patent)

IPR2016-1907 ('488 patent).

The motion will request that the Board terminate each of these IPRs under 35 U.S.C.

§ 317 and withdraw the decisions issued in IPRs 2016-1372 and -1381 as to which the period to request rehearing has not yet expired. The parties have conferred, and are in agreement on these motions.

The parties are available on [DATES AND TIMES TBD]should a conference be desired before authorizing the filing of the motions.

[NAMES OF COUNSEL FOR THE PATENT OWNER AND PETITIONER]

[CONTENT OF JOINT MOTIONS TO BE PREPARED BY COUNSEL]

0.0 01

Page 29CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EXHIBIT B

[***]

Page 30CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EXHIBIT C

[IMMERSION FORM W-9 ATTACHED]

Page 31CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Page 32CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Page 33CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Page 34CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

Page 35CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EXHIBIT D

[IMMERSION PRESS RELEASE ATTACHED]

Page 36CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

IMMERSION REACHES GLOBAL SETTLEMENT WITH APPLE

SAN JOSE, Calif., January 29, 2018-Immersion Corporation (Nasdaq: IMMR), the leading developer and licensor of touch feedback technology, today announced that the Company has entered into settlement and license agreements with Apple, the terms of which are confidential.

About Immersion Corporation

Immersion is the leading innovator of touch feedback technology, also known as haptics. The company provides technology solutions for creating immersive and realistic experiences that enhance digital interactions by engaging users’ sense of touch. With more than 2,600 issued or pending patents, Immersion’s technology has been adopted in more than 3 billion digital devices, and provides haptics in mobile, automotive, advertising, gaming, medical and consumer electronics products. Immersion is headquartered in San Jose, California with offices worldwide. Learn more at www.immersion.com.

Immersion and the Immersion logo are trademarks of Immersion Corporation in the United States and other countries.

(IMMR - C)

Contacts

Immersion Corporation

Nancy Erba, Chief Financial Officer

408-350-8850

nerba@immersion.com

The Blueshirt Group

Jennifer Jarman

+1 415.217.5866

jennifer@blueshirtgroup.com

Page 37CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT

BETWEEN IMMERSION AND APPLE

[***] Confidential Treatment Request

EX-31.1

Exhibit 31.1

CERTIFICATIONS PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Carl Schlachte, certify that:

I have reviewed this quarterly report on Form 10-Q/A of Immersion Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 30, 2018

/s/   CARL SCHLACHTE

Carl Schlachte

Interim Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Nancy Erba, certify that:

I have reviewed this quarterly report on Form 10-Q/A of Immersion Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 30, 2018

/s/ Nancy Erba

Nancy Erba

Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Immersion Corporation (the “Company”) on Form 10-Q/A for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Carl Schlachte, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/   CARL SCHLACHTE

Carl Schlachte

Interim Chief Executive Officer

July 30, 2018

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Immersion Corporation (the “Company”) on Form 10-Q/A for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Nancy Erba, Chief Financial Officer, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Nancy Erba

Nancy Erba

Chief Financial Officer

July 30, 2018

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.